Valuation check: MRM's profit margin is 2.32%, below the Consumer Discretionary sector average of 9.32%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
The latest profit margin for MRM is 2.32% as of December 2025. That compares with 1.46% in the prior-year period — up 59.6% year over year. That is below the Consumer Discretionary sector average of 9.32%. Investors often review this figure alongside MEDIROM Healthcare Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, MRM's profit margin moved from 1.46% to 2.32% — a 59.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MEDIROM Healthcare Technologies's valuation or profitability profile.
Against Consumer Discretionary companies, MRM currently prints 2.32% for profit margin, while the sector average sits near 9.32%. That is roughly 75.1% below the sector mean. Large gaps often invite a closer look at MEDIROM Healthcare Technologies's growth, margins, and balance sheet.
Profit Margin shows how effectively MEDIROM Healthcare Technologies converts resources into returns. At 2.32%, MRM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 1.46% in the prior-year period — up 59.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MRM's profit margin (2.32%), review year-over-year change from 1.46%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.